top of page


At Cognitact, we are translating cutting-edge research efforts into a risk prediction, diagnostic, and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood. 

What is Alzheimer's Disease (AD) ?

An age-related, progressive chronic disease that affects populations worldwide mainly after the age of 65 - changes occur in the brain

20 years before clinical onset.

Major symptoms include: 

Why do we need to early intervention of AD?

  • Patients are diagnosed too late: disease appears many years before actual diagnosis ⇨ miss the golden period for treatment

Early intervention delays the onset of AD!

Our Service

We provide:

  •  Risk prediction for AD

  •  Assisting AD diagnosis

  •  Suggestion for AD risk     management

Accuracy up to 96%


Our Mission

We are aspired to enable the public to receive more convenient and accurate predictions and diagnoses in neurodegenerative diseases. We hope to bring forth the next generation of Alzheimer's disease prediction and diagnostic tools for everyone through translating big data discoveries into molecular diagnostics.

Contact Us

Thank you for your interest in our research.

Get in touch with us for any questions or comments regarding our work and publications.

Our location: Office 627, 6/F, Building 16W, Hong Kong Science Park,

Shatin, N.T., Hong Kong, China


Phone: +852 2116-1678

bottom of page